A Trial to Assess the Pain-control Efficacy of Intra-articular Toradol Compared to Oral NSAIDs
NCT ID: NCT02966288
Last Updated: 2020-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2017-01-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Toradol injection
3-ml solution that contains 2 ml of normal saline and 1 ml of Toradol, 30 mg, will be infused into the affected joint.
Toradol
3-ml solution that contains 2 ml of normal saline and 1 ml of Toradol, 30 mg, will be infused into the affected joint.
Oral NSAID
800mg Motrin will be administered. (non-steroidal anti-inflammatory drug (NSAID))
Oral NSAID
800mg Motrin will be administered. (non-steroidal anti-inflammatory drug (NSAID))
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Toradol
3-ml solution that contains 2 ml of normal saline and 1 ml of Toradol, 30 mg, will be infused into the affected joint.
Oral NSAID
800mg Motrin will be administered. (non-steroidal anti-inflammatory drug (NSAID))
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Intra-articular steroid injection within 6 months
* History of gout or rheumatoid arthritis
* X ray evidence of pathologic fracture, malignancy, or other non-OA cause of symptoms
* Signs or symptoms or high risk of acute infection: Recent fevers and chills; Erythema, warmth, or pain out of proportion to exam; History of hemodialysis; History of IV drug use
* Lidocaine allergy
* Any contraindication to NSAID therapy, including: Allergy; Pregnancy; History of renal insufficiency; History of gastritis, GERD or GI bleeding; Primary care physician's restriction of its use
* Contraindication to the procedure, including: Hemophilia; History of total knee replacement of the affected joint
* An inability to give informed consent; Active psychosis; Diminished capacity requiring another person to provide consent for medical treatment
* An inability to be contacted for follow-up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kimberly A Chambers
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kimberly A Chambers, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-16-0616
Identifier Type: -
Identifier Source: org_study_id